Kids with Cancer

Justin Miller Begins Treatment to Cure Childhood Cancer Number 6

by Lori Miller
April 10, 2013

We are in the clinic waiting room at Children’s Hospital of Philadelphia, preparing to be seen and admitted to the special room. Cancer fighting #6 is about to begin…

A little more than a year ago we were experiencing this same MIBG therapy for advanced-stage neuroblastoma in New York. We hope we are more prepared this time.

Justin fully understands what the next few days will bring: the lead-lined room, the isolation, the feelings of being a “caged animal” where whatever goes in, can’t come out. We’ve talked with him about how restricted Grandma and I will be from being able to take care of him, touch him, hug him and love on him.

Read more »


Neuroblastoma Expert to Lead Pediatric Dream Team

by St. Baldrick's Foundation
April 7, 2013


Dr. John M. Maris, SU2C – St. Baldrick’s Pediatric Dream Team Leader

Dr. Crystal Mackall and Dr. John Maris will co-chair the SU2C-St. Baldrick’s Foundation Immunogenomics Dream Team.

Even before he started medical school, physician and scientist John M. Maris, MD, was interested in neuroblastoma, a cancer that starts in young nerve cells and can spread quickly through a child’s body. It is one of the most common cancers in children, and the most common cancer in infants.

As he continued studying the disease, Dr. Maris became convinced that neuroblastoma was a genetic disease and that genetic research could unlock new treatments for kids with cancer. Since then, Dr. Maris has devoted his career to curing neuroblastoma, a passion that has fueled over two decades of research.

Read more »


Announcing the Stand Up To Cancer – St. Baldrick’s Pediatric Cancer Dream Team [VIDEO]

by Kathleen Ruddy, CEO, St. Baldrick's Foundation
April 7, 2013

I wish you could have been with us in the room when the first pediatric cancer Dream Team was announced, to be funded by the partnership of the St. Baldrick’s Foundation and Stand Up To Cancer (SU2C).

From a long list of innovative “big ideas,” the scientific reviewers representing both funding organizations had chosen the top four to submit detailed proposals. The experts agreed that any of these would be great investments, but for a grant of $14.5 million over four years, only one could be chosen.

The suspense ended with an enthusiastic round of applause when the winning Dream Team was announced at a reception tonight at the annual meeting of the American Association of Cancer Research (AACR). The evening’s emcee was actor Kyle MacLachlan, and speakers included Nobel Laureate Dr. Philip Sharp, St. Baldrick’s CEO Kathleen Ruddy, and 10-year-old cancer survivor Emma W. and her parents.

And the award goes to:

Read more »